Godsey & Gibb Inc’s TuHURA Biosciences HURA Stock Holding History

Godsey & Gibb Inc’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10	Closed	-$25	–	469
2025 Q3	$25	Buy	+10	New	+$26	﹤0.01%	372

Other funds holding HURA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Godsey & Gibb Inc's HURA Position: Q4 2025 in Review

Godsey & Gibb Inc sold out of TuHURA Biosciences (HURA) in Q4 2025, closing a stake of 10 shares — an estimated $25 sold.

Godsey & Gibb Inc first reported a position in HURA in Q3 2025 and held it in 1 quarter. The position peaked at $25 in Q3 2025. 65 funds tracked by Wall St. Rank hold HURA as of Q4 2025.

Godsey & Gibb Inc reported no remaining TuHURA Biosciences position as of Q4 2025 after selling out during the quarter.
Godsey & Gibb Inc sold 10 TuHURA Biosciences shares in Q4 2025, an estimated $25.
Godsey & Gibb Inc first reported a position in TuHURA Biosciences in Q3 2025 and held it in 1 quarter.
Godsey & Gibb Inc's TuHURA Biosciences position peaked at $25 in Q3 2025.
65 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2025.

Based on Godsey & Gibb Inc's 13F filing for Q4 2025, filed 27 Jan 2026.